Fact CheckerSign in

NCT06131619Completed

The Role of DLOTCA-G in the Cognitive Function Evaluation of Parkinson's Patients

The Role of Dynamic Lowenstein Occupational Therapy Cognitive Assessment-Geriatric Version (DLOTCA-G) in the Cognitive Function Evaluation of Parkinson's Patients

Source: ClinicalTrials.gov · Last updated 20 Mar 2024

Brief summary (registry, in English)

The purpose of this study is to evaluate the usefulness of Dynamic Loewenstein's Occupational Therapy and Cognitive Assessment Scale for Geriatrics (DLOTCA-G) in parkinson patients.

Status (registry)
Completed
Study type
Observational
Enrollment
90 (actual)
First submitted
9 Nov 2023
Start date
5 Jun 2022
Primary completion date
24 Jan 2024
Lead sponsor
Kutahya Health Sciences University
NCT number
NCT06131619

What you commit to

  • Study type: Observational
  • Participants enrolled: 90
  • From 5 Jun 2022 to the primary completion date, 24 Jan 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Inclusıon Criteria
  • Parkinson's patients aged 65 years and older with and without cognitive impairment (60 patients) and healthy control patients (30 patients)
  • Hoehnn Yahr Staging between 1 and 2.5 in patients with Parkinson's diseas
  • Confirmed by brain MRI from patients without vascular dementia who routinely attend the Parkinson's follow-up outpatient clinic
  • At least primary school graduates
  • In patients with Parkinson's dissease patients with cognitive impairment, MMSE below 20 in primary school education level; below 24 in secondary, high school and university education level
  • In patients with Parkinson's disease without cognitive impairment, MMSE 20 and above in primary school education level; 24 and above in secondary, high school and university education level Exclusıon Criteria
  • Preexisting cognitive impairment
  • Psychiatric disorders such as psychotic disorders, mood disorders, alcohol or drug abuse
  • Severe language dysfunction and/or bilateral limb motor dysfunction and inability to participate in clinical psychology tests, severe visual and/or auditory impairments
  • Patients with significant cerebral atrophy or neurological vascular lesions
  • The Geriatric Depression Scale was administered to all participants, and participants with a total score of 13 or more out of 30 points were excluded from the study.

Age in the registry: 65 years to 90 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kütahya Health Sciences University
Coordinator of this site? Confirm its status
KütahyaTurkey (Türkiye)Unknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.